Patents by Inventor Jack S. Cohen

Jack S. Cohen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Inhibitors for replication of retroviruses and for the expression of oncogene products
    Patent number: 5286717
    Abstract: Phosphorothioate oligodeoxyribonucleotide analogs can be used to prevent replication of foreign nucleic acids in the presence of normal living cells, as well as to inhibit the proliferation of neoplastic cells.
    Type: Grant
    Filed: November 16, 1992
    Date of Patent: February 15, 1994
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Jack S. Cohen, Len Neckers, Cy Stein, She L. Loke, Kazuo Shinozuka
  • Inhibitors for replication of retroviruses and for the expression of oncogene products
    Patent number: 5276019
    Abstract: Phosphorothioate oligodeoxyribonucleotide analogs can be used to prevent replication of foreign nucleic acids in the presence of normal living cells, as well as to inhibit the proliferation of neoplastic cells.
    Type: Grant
    Filed: February 22, 1988
    Date of Patent: January 4, 1994
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Jack S. Cohen, Len Neckers, Cy Stein, Shee L. Loke, Kazuo Shinozuka
  • Inhibitors for replication of retroviruses and for the expression of oncogene products
    Patent number: 5264423
    Abstract: Phosphorothioate oligodeoxyribonucleotide analogs can be used to prevent replication of foreign nucleic acids in the presence of normal living cells, as well as to inhibit the proliferation of neoplastic cells.
    Type: Grant
    Filed: November 16, 1992
    Date of Patent: November 23, 1993
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Jack S. Cohen, Len Neckers, Cy Stein, She L. Loke, Kazuo Shinozuka
  • Use of paramagnetic metalloporphyrins as contrast agents for tumors in MRI imaging
    Patent number: 4986256
    Abstract: Water-soluble paramagnetic metalloporphyrins are used as contrast enhancing agents for magnetic resonance imaging. These agents exhibit excellent localization, non-toxicity and suprisingly high contrast enhancement in magnetic resonance imaging applications.
    Type: Grant
    Filed: February 28, 1985
    Date of Patent: January 22, 1991
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Jack S. Cohen, Chi-Wan Chen, Charles E. Myers, Miriam Sohn